Telmisartan and Amlodipine

Product NDC
62332-186
Requested package NDC
62332-186-10
11-digit product format
623320186
Labeler code
62332
Product ID
62332-186_3c17512c-6361-49b7-8531-a45ab1342de7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Telmisartan and Amlodipine
Dosage form
TABLET
Route
ORAL
Labeler
Alembic Pharmaceuticals Inc.
Application
ANDA205234
Marketing category
ANDA
Marketing start
2026-03-31
Substance
TELMISARTAN; AMLODIPINE BESYLATE
Active strength
80; 5 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A205234-001TELMISARTAN AND AMLODIPINEAMLODIPINE BESYLATE; TELMISARTANEQ 5MG BASE;40MGTABLET / ORAL2016-11-17
A205234-002TELMISARTAN AND AMLODIPINEAMLODIPINE BESYLATE; TELMISARTANEQ 10MG BASE;40MGTABLET / ORAL2016-11-17
A205234-003TELMISARTAN AND AMLODIPINEAMLODIPINE BESYLATE; TELMISARTANEQ 5MG BASE;80MGTABLET / ORAL2016-11-17
A205234-004TELMISARTAN AND AMLODIPINEAMLODIPINE BESYLATE; TELMISARTANEQ 10MG BASE;80MGTABLET / ORAL2016-11-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 180 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-17d4dbc9d85df4…
2026-11-14 07:37:172026-10A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-17d4dbc9d85df4…
2026-11-14 07:37:172026-10A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-17d4dbc9d85df4…
2026-11-14 07:37:172026-10A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-17d4dbc9d85df4…
2026-10-15 13:18:302026-09A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-17c2088c7a36db…
2026-10-15 13:18:302026-09A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-17c2088c7a36db…
2026-10-15 13:18:302026-09A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-17c2088c7a36db…
2026-10-15 13:18:302026-09A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-17c2088c7a36db…
2026-09-14 22:38:342026-08A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-1784e616aacf4f…
2026-09-14 22:38:342026-08A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-1784e616aacf4f…
2026-09-14 22:38:342026-08A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-1784e616aacf4f…
2026-09-14 22:38:342026-08A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-1784e616aacf4f…
2026-08-18 06:07:402026-07A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-17caaa826d4ba7…
2026-08-18 06:07:402026-07A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-17caaa826d4ba7…
2026-08-18 06:07:402026-07A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-17caaa826d4ba7…
2026-08-18 06:07:402026-07A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-17b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-17b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-17b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A205234-001TELMISARTAN AND AMLODIPINEEQ 5MG BASE;40MGTABLET / ORAL2016-11-1703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A205234-002TELMISARTAN AND AMLODIPINEEQ 10MG BASE;40MGTABLET / ORAL2016-11-1703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A205234-003TELMISARTAN AND AMLODIPINEEQ 5MG BASE;80MGTABLET / ORAL2016-11-1703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A205234-004TELMISARTAN AND AMLODIPINEEQ 10MG BASE;80MGTABLET / ORAL2016-11-1703ed91905a0d…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-12-13 00:20 UTC2019-12A205234-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A205234-002AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A205234-003AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A205234-004AB174a2ff9319b5…
2020-11-12 02:37 UTC2020-11A205234-001AB1c0c555d07b60…
2020-11-12 02:37 UTC2020-11A205234-002AB1c0c555d07b60…
2020-11-12 02:37 UTC2020-11A205234-003AB1c0c555d07b60…
2020-11-12 02:37 UTC2020-11A205234-004AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A205234-001AB13f01610625f2…
2019-12-14 00:12 UTC2019-12A205234-002AB13f01610625f2…
2019-12-14 00:12 UTC2019-12A205234-003AB13f01610625f2…
2019-12-14 00:12 UTC2019-12A205234-004AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A205234-001AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A205234-002AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A205234-003AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A205234-004AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A205234-001AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A205234-002AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A205234-003AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A205234-004AB1ea99ee380514…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Telmisartan and Amlodipine
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TELMISARTAN80 mg/1
AMLODIPINE BESYLATE5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
U5SYW473RQInternal UNII lookup
864V2Q084HInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
876514Internal RxNorm lookup
876519Internal RxNorm lookup
876524Internal RxNorm lookup
876529Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
14f9b590-4c43-439c-a647-9fc2b0fd4d7fAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Telmisartan and AmlodipineTELMISARTAN AND AMLODIPINEAlembic Pharmaceuticals Limited15b438b4-4874-43f4-a50a-4e6f3e5530ac2026-10-26Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 205234
application number: ANDA205234
Telmisartan and AmlodipineTELMISARTAN AND AMLODIPINEAlembic Pharmaceuticals Inc.14f9b590-4c43-439c-a647-9fc2b0fd4d7f2026-10-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 205234
application number: ANDA205234
ndc (package): 62332-186-10
ndc (product): 62332-186
ndc11 (package): 62332018610

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
62332-186-106233201861030 BLISTER PACK in 1 CARTON (62332-186-10) / 10 TABLET in 1 BLISTER PACK (62332-186-03) 30 blister pack2026-03-31NoNoCurrent